U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: May 29 - June 4, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: May 29 - June 4, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 06/01/2022
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Richard Ball, Ted McKinney (National Association of State Departments of Agriculture);

Event Date: 06/02/2022
Location: Virtual
Subject: FDA Priorities
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Association of Clinical Research Organizations Board of Directors and Staff

Event Date: 06/03/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Alexandre Biella, Arthur Pike, Audrae Erickson, Jeffrey Fischer, Robert Cleveland (Reckitt);

Event Date: 06/03/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several industry groups interested in the infant formula issue

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 05/31/2022
Location: Virtual
Subject: Accelerating Medicines Partnership (AMP) Extended Executive Committee Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from National Institutes of Health (NIH)

Event Date: 06/01/2022
Location: Virtual
Subject: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-2/-3/-6 Trial Oversight Committee Meeting
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in accelerating clinical trial development

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 05/31/2022
Location: Virtual
Subject: Animal Wellness Issues Listening Session
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Associates from Animal Wellness Action

Event Date: 06/02/2022
Location: Virtual
Subject: Antimicrobial Resistance Listening Session
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from a coalition of stakeholder groups working to address antimicrobial resistance issues

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 06/01/2022
Location: Virtual
Subject: Infant Formula Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members and staff from the National Governors Association and government

Event Date: 06/03/2022
Location: Virtual
Subject: Hazard Analysis and Risk-Based Preventive Controls for Human Food: Draft Guidance for Industry
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several U.S. Food and Beverage Trade Associations and members of the Food and Beverage Issue Alliance

Event Date: 06/03/2022
Location: Virtual
Subject: Infant Formula Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS;
Non FDA Participant/Group: Ben Reich, Brad LaRock (Datasembly);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 05/31/2022
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: DANIEL CANOS; ANDREW FARB; CHARLES VIVIANO; RANDALL BROCKMAN; DONALD MILLER;
Non FDA Participant/Group: Judi Buckalew, Keith Hume, Matthew Johnson, Parag Patel, Robert Lewandowski (Society of Interventional Radiology);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 06/02/2022
Location: Virtual Zoom
Subject: Plant Genome Editing
FDA Participant/Group: LAURA EPSTEIN; JASON DIETZ; KATHLEEN JONES; KATHLEEN JONES; KARI BARRETT; FELICIA ELLISON; SIOBHAN DELANCEY; CARRIE MCMAHON; KAREN HATWELL; STEVEN MUSSER; PHILIP CHAO; KRISTI MULDOON JACOBS; DAVID EDWARDS;
Non FDA Participant/Group: Andy LaVigne, Fan-Li Chou, Janae Brady (American Seed Trade Association (ASTA));

Official Name: Michele Mital, Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top